Hence, CD13 interacted with HDAC5 to increase the stabilization of LSD1, which demethylated p65 (50, 116) and thereby stabilized it and increased p65/NF-κB signaling; this resulted in sorafenib resistance and HCC progression (95). Here, HDAC5 is linked to hepatocellular carcinoma.